Aurinia Pharmaceuticals (AUPH) Inventory Average (2021 - 2026)

Aurinia Pharmaceuticals (AUPH) has 6 years of Inventory Average data on file, last reported at $46.0 million in Q1 2026.

• Quarterly Inventory Average rose 7.82% year-over-year to $46.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.0 million (up 7.82% YoY) and the FY2025 annual result came in at $42.5 million, up 7.58% from the prior year.
• Inventory Average climbed to $46.0 million in Q1 2026, from $45.2 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $46.3 million in Q2 2025 to a low of $22.8 million in Q1 2022.
• A 5-year average of $36.0 million and a median of $38.8 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2022 — Inventory Average soared 56.49% — and 2024, when it gained 7.47%.
• Tracing AUPH's Inventory Average over 5 years: stood at $25.0 million in 2022, then soared by 44.84% to $36.3 million in 2023, then advanced by 7.47% to $39.0 million in 2024, then rose by 16.09% to $45.2 million in 2025, then advanced by 1.79% to $46.0 million in 2026.
• The last three Inventory Average figures came in at $46.0 million (Q1 2026), $45.2 million (Q4 2025), and $45.6 million (Q3 2025), per Business Quant data.